Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 2 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN PLASTIC CONTAINER.
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of glucose for cellular metabolism, primarily via glycolysis and the Krebs cycle, to produce ATP. Sodium chloride maintains fluid and electrolyte balance, acting as a source of sodium and chloride ions essential for osmotic pressure and acid-base homeostasis.
Magnesium sulfate causes decreased release of acetylcholine at the neuromuscular junction, reducing muscle contractility. It also blocks calcium channels, leading to vasodilation and anticonvulsant effects.
Intravenous infusion: 100-200 mL/hour per 70 kg adult; rate adjusted based on fluid and electrolyte needs, typically 0.5-4 mL/kg/hour.
IV: 1-4 g as a 10-20% solution, rate not exceeding 1 g/min; for eclampsia: 4-5 g IV bolus then 1-2 g/hour IV infusion.
None Documented
None Documented
Not applicable; dextrose and electrolytes are endogenous substances, not subject to classic elimination half-life. Plasma glucose half-life is ~15-20 minutes in euglycemic conditions due to rapid cellular uptake.
Normal renal function: 4–6 hours (terminal). In oliguria or anuria, half-life may extend to >24 hours, requiring dose adjustment.
Dextrose: primarily metabolized to CO2 and water; <1% excreted unchanged renally. Sodium chloride: electrolytes are reabsorbed or excreted renally; no specific elimination pathway.
Primarily renal (glomerular filtration); >90% excreted unchanged in urine. Biliary/fecal elimination is negligible (<1%).
Category A/B
Category C
Electrolyte
Electrolyte